Plasma levels of TIMP-1 in chemo-naive patients with metastatic colorectal cancer treated with first-line FLOX with or without cetuximab: Results from the Nordic VII Study

Research output: Contribution to conference without publisher/journalPosterResearch

Original languageEnglish
Publication date24. Jan 2013
Publication statusPublished - 24. Jan 2013

Cite this